ARA290 (cibinetide) treatment confers neuroprotective effects in diabetic retinopathy, through modulation of inflammatory mediators.Paul Canning, Alan W. Stitt, Olivia O'Leary et al.|Investigative Ophthalmology & Visual Science|2019Cited by 1